These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4783660)

  • 41. [Development of immunity to the poliomyelitis virus in infants with various methods of administering a live poliomyelitis vaccine].
    Drozdov SG; Zhevandrova VI; Smirnova GA; Shmel'kov IuA; Kodkind GKh
    Vopr Virusol; 1979; (3):252-9. PubMed ID: 223328
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Serological control over the state of immunity to the poliomyelitis virus in children].
    Kaplan AS; Vasilevskaia NI; Kozhevnikov IN; Stepanova GS
    Vopr Virusol; 1974; (4):418-23. PubMed ID: 4373926
    [No Abstract]   [Full Text] [Related]  

  • 43. Herd immunity to poliovirus in Dundee.
    Smith WC; Small RG; Dunkerley RA; Green DM
    Health Bull (Edinb); 1982 Nov; 40(6):296-305. PubMed ID: 6298147
    [No Abstract]   [Full Text] [Related]  

  • 44. [Behaviour and properties of poliomyelitis coproantibodies using the "antiglobin test" and the conventional neutralisation test (author's transl)].
    Albano A; De Donato S; Scarinci V; Jakschik M
    Zentralbl Bakteriol Orig A; 1974 Feb; 226(1):1-11. PubMed ID: 4152333
    [No Abstract]   [Full Text] [Related]  

  • 45. A poliomyelitis immunity survey in Hillsborough County, Florida.
    Witte JJ; Neill JS; Prather EC; Casey HL; Bond JO
    South Med J; 1973 Jun; 66(6):696-9. PubMed ID: 4708571
    [No Abstract]   [Full Text] [Related]  

  • 46. Present status of measles and rubella immunization in the United States: a medical progress report.
    Krugman S
    J Pediatr; 1971 Jan; 78(1):1-16. PubMed ID: 5539083
    [No Abstract]   [Full Text] [Related]  

  • 47. [Immunity to measles, mumps and rubella in children vaccinated with triple viral vaccine].
    Pisón Garcés FJ; Galbe Sánchez-Ventura J; Arcauz Eguren P; Aguirre y Dabán C; Mengual Gil J; Larrad Mur L
    Aten Primaria; 1995 Mar; 15(4):235-7. PubMed ID: 7703334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.
    Goujon C; Gougeon ML; Tondeur L; Poirier B; Seffer V; Desprès P; Consigny PH; Vray M;
    Vaccine; 2017 Oct; 35(45):6166-6171. PubMed ID: 28958813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A seroprevalence study of poliovirus antibody in the population of northern Greece.
    Frantzidou F; Diza E; Halkia D; Antoniadis A
    Clin Microbiol Infect; 2005 Jan; 11(1):68-71. PubMed ID: 15649308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Poliomyelitis outbreak in Israel in 1988: a report with two commentaries.
    Slater PE; Orenstein WA; Morag A; Avni A; Handsher R; Green MS; Costin C; Yarrow A; Rishpon S; Havkin O
    Lancet; 1990 May; 335(8699):1192-5; discussion 1196-8. PubMed ID: 1971043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Status of immunity in the population against poliomyelitis. I].
    Monaci V; Nardi G; Bellelli E
    Ann Sclavo; 1971; 13(3):305-22. PubMed ID: 5153359
    [No Abstract]   [Full Text] [Related]  

  • 52. The current state of immunity to polioviruses in New South Wales.
    Murphy AM; Hardie A; Stout M; Field PR; James BR
    Med J Aust; 1972 Dec; 2(25):1404-8. PubMed ID: 4346662
    [No Abstract]   [Full Text] [Related]  

  • 53. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Humoral immunity status against poliomyelitis in the Piedmont population 15 years after the introduction of vaccination with Sabin oral vaccine].
    Giuliani G; Frezet D; Paggi GC; Varetti G
    Ann Sclavo; 1982; 24(1):5-15. PubMed ID: 6303233
    [No Abstract]   [Full Text] [Related]  

  • 55. Long-term immunity to poliovirus in children immunized with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines.
    Faden H; Duffy L; Sun M; Shuff C
    J Infect Dis; 1993 Aug; 168(2):452-4. PubMed ID: 8335983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Poliomyelitis outbreak in South Africa, 1982. II. Laboratory and vaccine aspects.
    Johnson S; Schoub BD; McAnerney JM; Gear JS; Moodie JM; Garrity SL; Klaassen KI; Küstner HG
    Trans R Soc Trop Med Hyg; 1984; 78(1):26-31. PubMed ID: 6324420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Poliomyelitis immunity status in Italian and foreign subjects.
    Tanzi ML; Bracchi U; Affanni P; Dall'Argine A; Bombarda G; Bellelli E
    Ann Ig; 1992; 4(4):191-7. PubMed ID: 1284576
    [No Abstract]   [Full Text] [Related]  

  • 58. [Levels of antibodies against rubella and evaluation of immunity conferred by vaccination in Tucuman, Argentina].
    de Paulino I; Komaid JA; de Castagnaro NR; Raya JM
    Bol Oficina Sanit Panam; 1979 Jun; 86(6):529-33. PubMed ID: 157758
    [No Abstract]   [Full Text] [Related]  

  • 59. Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?
    Ogra PL
    Public Health Rev; 1993-1994; 21(1-2):143-50. PubMed ID: 8041881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Response of revaccination against polio I in seronegative children after receiving 3 or more doses of the vaccine].
    Ruiz-Gómez J; Sánchez Burgos Y; Arrayales Sandoval F; Velázquez Zúñiga C
    Gac Med Mex; 1977 Jan; 113(1):23-7. PubMed ID: 863152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.